Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test
Test Name: Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test
Components: RB1, MYCN
Price: 5730.0 AED
Sample Condition: Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery: Sample Daily by 9 am; Report 45 days
Method: NGS, Sanger sequencing
Test type: Retinoblastoma-Eye cancer
Doctor: Ophthalmologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
About the Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test
Hereditary retinoblastoma is a rare genetic condition that affects the eyes and can lead to vision loss or blindness. It is caused by mutations in the RB1 gene, which is responsible for regulating cell growth and division. Individuals with hereditary retinoblastoma have a higher risk of developing tumors in both eyes, as well as other parts of the body.
Nx Gen sequencing is a genetic testing method that uses advanced technology to analyze the DNA sequence of the RB1 gene. This test can identify mutations or changes in the gene that may be associated with hereditary retinoblastoma. By detecting these mutations early, individuals at risk for the condition can receive appropriate medical care and monitoring to prevent or manage the development of tumors.
The Nx Gen sequencing test for hereditary retinoblastoma is typically recommended for individuals with a family history of the condition or those who have been diagnosed with retinoblastoma in one eye. It may also be used for prenatal testing in families with a known RB1 gene mutation.
Overall, the Nx Gen sequencing test for hereditary retinoblastoma can provide valuable information about an individual’s genetic risk for this condition and guide medical management decisions.
| Test Name | Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test |
|---|---|
| Components | RB1, MYCN |
| Price | 5730.0 AED |
| Sample Condition | Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
| Report Delivery | Sample Daily by 9 am; Report 45 days |
| Method | NGS, Sanger sequencing |
| Test type | Retinoblastoma-Eye cancer |
| Doctor | Ophthalmologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
| Test Details |
Hereditary retinoblastoma is a rare genetic condition that affects the eyes and can lead to vision loss or blindness. It is caused by mutations in the RB1 gene, which is responsible for regulating cell growth and division. Individuals with hereditary retinoblastoma have a higher risk of developing tumors in both eyes, as well as other parts of the body. Nx Gen sequencing is a genetic testing method that uses advanced technology to analyze the DNA sequence of the RB1 gene. This test can identify mutations or changes in the gene that may be associated with hereditary retinoblastoma. By detecting these mutations early, individuals at risk for the condition can receive appropriate medical care and monitoring to prevent or manage the development of tumors. The Nx Gen sequencing test for hereditary retinoblastoma is typically recommended for individuals with a family history of the condition or those who have been diagnosed with retinoblastoma in one eye. It may also be used for prenatal testing in families with a known RB1 gene mutation. Overall, the Nx Gen sequencing test for hereditary retinoblastoma can provide valuable information about an individual’s genetic risk for this condition and guide medical management decisions. |
